Novartis progresses with clinical trials in chronic myeloid leukemia

Swiss drug major Novartis NOVN VX has released an update on its clinical trial program on evaluating the potential for patients with Philadelphia chromosomepositive chronic myeloid leukemia Ph CML to…
Read the full story: Bioportfolio Latest News